A new FDA-approved device, called a DBS device, claims to use adaptive deep brain stimulation to treat some with Parkinson's disease.

Patent-pending innovation cools high-density data centers with ‘just a sip of water,' half the power of traditional systems ...

The tantalising development has been reported by researchers at the Peter Doherty Institute for Infection and Immunity in ...

Growth is driven by increasing epigenetic research influenced by clinical evidence linking epigenetics to various diseases. Epigenetic therapeutics, especially targeting DNMT, IDH, HDAC, and EZH2, are ...

Researchers have identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an ...

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer ...

Researchers at the University of Michigan Rogel Cancer Center identified a gene that plays a key role in prostate cancer ...

Combination of mitoxantrone hydrochloride liposome with cyclophosphamide, vincristine, and prednisone (CMOP) for patients with treatment-naïve peripheral T-cell lymphomas (PTCLs): Extended follow-up ...

Several Rpd3-like HDAC complexes have also been observed in mammals 18,19. Elucidation of their function has been hampered, however, by the much more convoluted and redundant nature of mammalian ...

Gotistobart in combination with pembrolizumab in patients with advanced melanoma who have progressed on PD-1 inhibitors with or without CTLA-4 inhibitors. This is an ASCO Meeting Abstract from the ...

Biodexa Pharmaceuticals PLC ("Biodexa” or the "Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company ...